Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea · Delayed Price · Currency is KRW 1,999.00
-31.00 (-1.53%)
At close: Oct 30, 2026
Biotoxtech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 31,426 | 44,254 | 52,429 | 98,113 | 119,140 | 117,384 | |
Market Cap Growth | -27.83% | -15.59% | -46.56% | -17.65% | 1.50% | -47.09% |
Enterprise Value | 60,409 | 75,280 | 78,212 | 127,342 | 128,169 | 118,446 |
Last Close Price | 1999.00 | 2815.00 | 3335.00 | 6160.00 | 8140.00 | 8020.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 38.06 | - | - | 43.72 | 16.50 |
Forward PE | - | 25.30 | 25.30 | 25.30 | 25.30 | 25.30 |
PS Ratio | 0.60 | 0.94 | 1.27 | 3.01 | 3.20 | 3.59 |
PB Ratio | 1.40 | 1.39 | 1.52 | 2.03 | 2.69 | 2.81 |
P/TBV Ratio | 1.00 | 1.14 | 1.37 | 1.96 | 2.79 | 2.96 |
P/FCF Ratio | 16.53 | 9.80 | - | - | - | - |
P/OCF Ratio | 5.67 | 6.67 | - | - | - | 27.01 |
PEG Ratio | - | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.15 | 1.60 | 1.89 | 3.90 | 3.44 | 3.62 |
EV/EBITDA Ratio | - | - | - | - | 46.70 | 18.79 |
EV/EBIT Ratio | - | - | - | - | 160.20 | 25.57 |
EV/FCF Ratio | 31.78 | 16.67 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 3.05 | 1.96 | 1.83 | 1.28 | 1.11 | 0.65 |
Debt / EBITDA Ratio | - | - | - | - | 17.90 | 4.29 |
Debt / FCF Ratio | 35.97 | 13.84 | - | - | - | - |
Net Debt / Equity Ratio | 1.75 | 1.08 | 0.89 | 0.43 | 0.41 | -0.03 |
Net Debt / EBITDA Ratio | -246.30 | -21.81 | -6.78 | -4.11 | 6.69 | -0.17 |
Net Debt / FCF Ratio | 20.57 | 7.61 | -3.37 | -0.99 | -0.57 | 0.34 |
Asset Turnover | 0.40 | 0.35 | 0.29 | 0.24 | 0.35 | 0.42 |
Inventory Turnover | 4.03 | 3.75 | 2.91 | 3.76 | 9.70 | 29.42 |
Quick Ratio | 0.39 | 0.44 | 0.50 | 0.62 | 0.64 | 0.77 |
Current Ratio | 0.54 | 0.57 | 0.72 | 0.86 | 0.83 | 0.83 |
Return on Equity (ROE) | -26.90% | -4.74% | -30.59% | -19.33% | 0.15% | 17.59% |
Return on Assets (ROA) | -2.20% | -2.76% | -3.80% | -3.98% | 0.46% | 3.75% |
Return on Invested Capital (ROIC) | -7.26% | -8.99% | -12.87% | -13.19% | 1.55% | 13.03% |
Return on Capital Employed (ROCE) | -13.10% | -12.80% | -16.00% | -12.10% | 1.20% | 10.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -12.99% | 2.63% | -12.26% | -4.97% | 2.29% | 6.06% |
FCF Yield | 6.05% | 10.20% | -17.35% | -21.09% | -26.85% | -2.79% |
Buyback Yield / Dilution | 1.80% | 11.10% | -13.90% | -5.42% | 4.91% | -5.41% |